WHAT MAKES OUR CHOICE OF BPC-157 DIFFERENT FROM OTHER BPC PEPTIDE SUPPLEMENTS
, Linder, M
gently swirl it until the powder is fully dissolved
For the beneficiary to qualify, a provider must submit a prior authorization request to the program that attests the beneficiary is prescribed the requested drug to reduce excess body weight and maintain weight reduction in combination with current and ongoing lifestyle modification including structured nutrition and physical activity consistent with the applicable FDA approved label, and the beneficiary is at least 18 years of age with a BMI greater than or equal to 35. For beneficiaries with underlying medical conditions, the BMI threshold is lowered to 30 or 25 based on the diagnosis
This condition, affecting one in three adults, is marked by fat buildup in the liver and, in its more severe forms, includes fibrosis and inflammation that can lead to cirrhosis or liver cancer
Lancet Diabetes Endocrinol 7(7):549559 Mok J et al (2023) Safety and efficacy of liraglutide, 3.0 mg, once daily vs placebo in patients with poor weight loss following metabolic surgery: the BARI-OPTIMISE randomized clinical trial